| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Wc & Surgical | EVP & Chief Commercial Officer
1 company
Rohit Kashyap last filed a Form 4 in August 2022, as President, Wc & Surgical at MDXG. Rohit Kashyap's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 430,072 shares of MDXG. The MDXG filings lean toward selling, a net 21,113 shares.
Rohit Kashyap has 5 Form 4 filings on record from August 2020 to August 2022, all as President, Wc & Surgical at Mimedx Group (MDXG), 2020–2022.
The 5 reported transactions were 3 stock awards and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $95K.
The largest open-market sale was 12,343 shares of MDXG at an average $4.21 on August 9, 2022, about $52K. Twelve months later MDXG was up 81%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.